Fund holders13F
Funds That Own CATALYST PHARMACEUTICALS INC (CPRX)
2 of the 26 major funds we track reported CPRX in their latest 13F, worth $78.0M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | 2,136,077 | $67.1M | ▼ −9.0% |
| Soros Fund Management | Q2 2026 | 344,593 | $10.8M | ▲ New |
| Fundsmith | Q2 2026 | 0 | $0 | ▼ Sold out |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →